Skip to main content
Equibles

China Universal Asset Management Co., Ltd.

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1906594 SHANGHAI, F4
Back to SUPN Full portfolio

Position in SUPN

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$429,612
-$96,333 QoQ
Shares Held
9,237
-9.2% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#188
of 335 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

China Universal Asset Management Co., Ltd. holds $16,477,419 across 28 Drug Manufacturers - Specialty & Generic names. SUPN ranks #8 (2.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 6,755 $3,660,061
2 VTRS
Viatris Inc
 185,339 $2,943,183
3 NBIX
Neurocrine Biosciences Inc
 16,003 $2,697,145
4 ALKS
Alkermes plc.
 26,527 $1,389,882
5 AMRX
Amneal Pharmaceuticals, Inc.
 50,773 $878,880
6 INDV
Indivior Pharmaceuticals, Inc.
 19,404 $796,146
7 KNSA
Kiniksa Pharmaceuticals International, plc
 7,369 $471,247
8 SUPN
Supernus Pharmaceuticals, Inc.
This page 		9,237 $429,612

All Filings in SUPN

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $429,612 9,237
2026-03-31 $525,945 10,175
2025-12-31 $613,447 12,343
2025-09-30 $641,771 13,429
2025-06-30 $669,642 21,245
2025-03-31 $633,778 19,352
2024-12-31 $718,354 19,866
2024-09-30 $330,476 10,599
2024-06-30 $172,778 6,459
2024-03-31 $357,813 10,490
2023-12-31 $182,727 6,314
2023-09-30 $38,625 1,401
2023-06-30 $21,462 714
2023-03-31 $26,556 733
2022-12-31 $19,582 549
2022-09-30 $16,958 501